Who Paid My Doc
Vericiguat in HFpEF
Research payments
$1,092,923
Through program year 2021, $1,092,923 in research payments was reported against Vericiguat in HFpEF, across 513 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $750 | 1 |
| 2020 | Research | $263,765 | 83 |
| 2019 | Research | $828,408 | 429 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Farhad Rafii West Hills, CA Named on 57 payments
- Venkatesh Nadar Camp Hill, PA Named on 36 payments
- Ferris George St Augustine, FL Named on 33 payments
- Vipul Shah Lancaster, SC Named on 29 payments
- Ghiath Mikdadi Hammond, LA Named on 29 payments
- Dalane Kitzman Winston Salem, NC Named on 28 payments
- Francisco Gonzalez Abreu Miami, FL Named on 26 payments
- David Henderson Daytona Beach, FL Named on 19 payments
- Eve Gillespie Kalispell, MT Named on 17 payments
- Lawrence Weinstein Boynton Beach, FL Named on 15 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.